Jul 8, 2022

GOHi initiated sero-prevalence study on SARS-CoV-2 in Ethiopia

The Ohio State Global One Health initiative (GOHi) is collaborating with the Ethiopian Public Health Institute (EPHI), U.S. Centers for Disease and Control (CDC), Africa CDC and World Health Organization (WHO) to carry out a cross-sectional, population-based sero-prevalence study on COVID-19. This study will involve more than 14,000 households in Ethiopia.

As part of the preparatory activities, the team conducted training to provide knowledge on sero-surveillance protocol, study procedures, research ethics, enumeration area map reading and electronic data capturing for field supervisors and data collectors. The training was delivered at the EPHI training center on July 4 and 5 and included didactic and practical sessions and discussions with project leads.

The overarching goal of conducting this randomized COVID-19 rapid antibody testing is to provide population-level sero-prevalence of SARS-CoV-2 in different time series, ages and sex strata, which will help authorities to monitor the disease trend.